| Molecular formula | C37H51N9O10S |
|---|
| Molecular weight | 813.9 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 9811102 |
|---|
What Semax Is
Semax is a synthetic peptide studied in research settings. It has no FDA-approved label, no approved brand name, and no approved indication in the data reviewed here. Its molecular formula is C37H51N9O10S, with a molecular weight of about 813.9, and it is catalogued under PubChem CID 9811102.
Regulatory Status
Semax is classified as an unapproved research compound. No DailyMed label exists for it, and there is no FDA-recognized indication, mechanism statement, or approved use to report.
Trial Footprint
The data reviewed here show no registered clinical trials for semax. No trial records or phase information are available to summarize at this time.
FAQ
No. Semax has no FDA-approved label, no approved brand name, and no approved indication based on the data reviewed. It is classified as an unapproved research compound.
Semax is a synthetic peptide with the molecular formula C37H51N9O10S and a molecular weight of about 813.9. It is identified in chemical databases under PubChem CID 9811102.
The data available here show no registered clinical trials for semax. Without trial records, no information on study design, phase, or outcomes can be reported.
No adverse event report data are available for semax in the dataset reviewed here. As a result, no side effect pattern can be summarized at this time.
No approved or labeled use exists for semax, and no indication information is available in the data reviewed. Because it remains an unapproved research compound, no use claims can be made.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-11-07